Rochester Medical Applauds Improved U.S. Medicare Coverage Policy for Intermittent Catheters

STEWARTVILLE, Minn., April 2, 2008  /PRNewswire-FirstCall/ -- Rochester Medical Corporation (NASDAQ:ROCM) applauds the improved U.S. Medicare coverage policy that now allows intermittent catheter users to benefit from not needing to reuse catheters.

Effective April 1, 2008, the four regional Durable Medical Equipment (DME) Medicare Administrative Contractors (MAC) covering the United States are implementing a new reimbursement policy covering the use of Intermittent Catheters.

The main policy change now allows an intermittent catheter user a maximum of 200 catheters per month instead of four catheters per month under previous policy.  Rochester Medical believes this is a very positive change in helping reduce urinary tract infections and improving the quality of life for Intermittent Catheter users.

Rochester Medical manufactures and markets a full line of advanced, all silicone Intermittent Catheters including, the only Antibacterial and Antibacterial Hydrophilic Intermittent Catheters in the marketplace. The Company expects the updated Medicare coverage policy will increase the usage of Intermittent Catheters and increase Rochester Medical's sales of Intermittent Catheters in the U.S.  At this time it is difficult to project the full scale of the change and the pace at which it will take effect.

This press release contains forward-looking statements that involve risks and uncertainties, including the uncertainty of the impact of the updated Medicare reimbursement policy for Intermittent Catheters and other risk factors listed from time to time in the Company's SEC reports and filings, including, without limitation, the section entitled "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended September 30, 2007.

Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications.  The Company markets under its own Rochester Medical(R) brand and under existing private label arrangements.

For further information, please contact Anthony J. Conway, President and Chief Executive Officer of Rochester Medical Corporation at [phone]. More information about Rochester Medical is available on its website at http://www.rocm.com/. 

DATASOURCE: Rochester Medical Corporation



CONTACT:  Anthony J. Conway, President and Chief Executive Officer of

Rochester Medical Corporation, [phone]



Web site:  http://www.rocm.com/ 

Copyright